The company's latest investment was a Venture Round at 23 December 2019 led by DOJIN CAPITAL. ImmuniT Research operates in the Biotechnology, Health Care, and Information Technology industries. Despite not having a specified headquarters, their focus on cutting-edge immunotherapy research and recent investment from DOJIN CAPITAL positions them as an emerging player in the biotech startup landscape.
General Information
Get notified when ImmuniT Research moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ImmuniT Research
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About ImmuniT Research
Taxonomy: Immunotherapy, Clinical Efficacy, Research, Immunological Analysis, BD LSRFortessa X-20, Immune Check Inhibitors, Precision Medicine, Biomedical Research, Innovation, Immunological Research
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
23 Dec 2019 |
ImmuniT Research Alternatives & Competitors
The Research Center for Molecular Medicine of the Austrian Academy of Sciences.
Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...
FAQ About ImmuniT Research
Don't just browse. Track.
Signal Tracker monitors ImmuniT Research and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.